Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · CAPILLARY TECHNO INDIA L · 28 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
CAPILLARY TECHNO INDIA L
NSE: CAPILLARY · BSE: 544614
Information Technology › Information Technology › IT - Software › Software Products

CAPILLARY TECHNO INDIA L

StateQ1 FY27 filed
Last close · 27 Oct 2026₹578.00
Market cap₹4.6k cr
TTM P/E · P/B · EV/EBITDA— · 4.49 · —

Sells an AI-powered cloud loyalty and engagement platform to large enterprises running consumer loyalty programmes. Revenue comes from subscriptions, with growth driven by three levers: existing customers expanding usage and absorbing price increases (FY26 organic net revenue retention of 114%), new enterprise logos, and acquiring legacy loyalty platforms at low margins and migrating them to a standardised 65% gross-margin setup. The aiRA AI stack, sold on usage-based pricing, is the fastest-adopted product in the company's history. In May 2026 the SessionM merchant loyalty business was acquired from Mastercard for $35 million, adding over 40 enterprise customers including five Fortune 500 firms and roughly INR 350 crore in annualised revenue. The platform runs at 99.999% uptime for 115 large enterprises. The largest cost is people — employee expenses were 48.2% of revenue in FY26 — followed by other operating expenses at 39.2%, depreciation at 10.2% and capex at 5.4%. AR · MarketPing reader · 2026-08-02

Revenue streams, as the annual report describes them. AI-powered loyalty & engagement platform. Asset-light, global AI-driven SaaS subscription platform with an M&A roll-up strategy.

What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.

Exhibit 1: Financial summary, FY26–FY26 (all audited; no estimate years)

₹ crore · consolidatedFY26
Revenue735
EBITDA (ex other income)118
margin %16.0
Owners' profit52
EPS, as reported (₹)6.94
ROE % · ROCE %5.1 · 5.4
Debt / equity (x)0.04
Cash from operations150
Capex(39)
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · CAPILLARY TECHNO INDIA L · 28 October 2026Page 2 of 3

Exhibit 2: Quarterly performance, last 3 quarters

₹ croreQ3 FY26Q4 FY26Q1 FY27
Revenue184191257
Profit before tax842(9)
Net profit843(10)
EPS (₹)1.055.47(1.20)
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.

Exhibit 3: Peers — basic industry group, by market cap

CompanyM.cap ₹ crP/EP/BEV/EBITDAROE %ROCE %Rev CAGR 5y %EBITDA m. %
ORACLE FIN SERV SOFT LTD.86,37425.311.0422.633.743.29.062.5
TANLA PLATFORMS LIMITED7,71614.43.109.220.525.013.517.6
CAPILLARY TECHNO INDIA L ◆4,593108.74.4935.05.14.9—4.9
C.E. INFO SYSTEMS LIMITED4,54433.05.0219.714.821.3—54.2
TECHNVISION VENTURES LTD.2,33710640.6155.78311.91.45.525.5(3.0)
Mobavenue AI Tech Limited2,04816.222.6242.832.430.8—21.8
RAMCO SYSTEMS LTD.1,90045.55.3712.311.911.02.316.0
NUCLEUS SOFTWARE EXPORTS1,77016.81.9510.112.915.211.316.9
Source: exchange data and filed statements via the screener; multiples at current prices.

Exhibit 4: Where the company sits in its group

MetricCompanyGroup medianRankBetter than
P/E (TTM)108.718.329 of 3210%
P/B4.51.530 of 3822%
ROCE4.94.820 of 4051%
ROE5.13.516 of 3860%
Debt / Equity0.00.024 of 3838%
EBITDA margin4.917.228 of 3521%
Market cap4593413 of 4495%
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · CAPILLARY TECHNO INDIA L · 28 October 2026Page 3 of 3

Exhibit 5: Filings of the last 90 days, with the measured price reaction

Date · filingCategoryImportanceNext day %5-day %
26 Oct 2026 · Q2 and H1 FY27 earnings call set for November 2board shareholder meetingslow——
26 Oct 2026 · Board to approve September quarter and half-year results on November 2board shareholder meetingslow——
22 Oct 2026 · William Swift appointed President, Americas and senior managermanagement changesmedium——
12 Oct 2026 · RTA certificate: no demat requests in Q2 FY27 as all shares are electroniccomplianceminimal——
30 Sept 2026 · Capillary Technologies announces schedule for analyst and investor meetingsboard shareholder meetingslow——
28 Sept 2026 · Analyst meet scheduled for October 1, 2026board shareholder meetingslow——
25 Sept 2026 · Capillary Tech clarifies price movement, says market-drivenregulatory legalmedium——
25 Sept 2026 · Exchange seeks clarification on share price movementregulatory legalmedium——
24 Sept 2026 · Trading Window closes from October 1, 2026 for Q2 resultscomplianceminimal——
24 Sept 2026 · Kotak Mutual Fund crosses 5% stake in Capillary Technologiesownership changeshigh——
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).

How to read this document

Where a broker report showsThis document showsWhy
A rating (BUY / ADD / REDUCE / SELL)A state: the latest filed quarter and the measured reactionsan event is a fact; a rating is an opinion that requires SEBI RA registration
A target price and upsideThe current price and the multiples against the groupa target is a forecast; a multiple is a measurement
Estimate years marked EMore audited years; no estimatesMarketPing publishes no forecasts — your own model lives on the Models page

Sources, method and disclosures

This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.

Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in